Eltrombopag Viatris

Eltrombopag Viatris is a medication used to stimulate platelet production. It is commonly prescribed for conditions affecting blood cell counts, such as thrombocytopenia. This oral medication is manufactured by Viatris Limited and is available in the EU market.

Eltrombopag Viatris is primarily used to increase platelet counts in individuals with certain blood disorders. It is often prescribed for conditions like chronic immune thrombocytopenia (ITP), where the body does not produce enough platelets. This medication helps in managing low platelet levels, which can reduce the risk of bleeding and bruising. Eltrombopag is also used in other conditions where platelet production is impaired.

Common effects of Eltrombopag Viatris may include headaches, nausea, and fatigue. Some individuals might experience dizziness or abdominal pain. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen. Eltrombopag can also affect liver function, so regular monitoring may be necessary.

Eltrombopag Viatris should be handled with care, especially by individuals with liver problems. It is important to follow the prescribed dosage and administration instructions. Pregnant or breastfeeding women should consult a healthcare provider before using this medication. Always store Eltrombopag in a cool, dry place away from direct sunlight.

Eltrombopag Viatris can interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect liver function should be avoided while using Eltrombopag. Always consult a healthcare provider before starting or stopping any medication.